Is transhumanism really the world’s most dangerous idea?
By Michael Cook,
Mercatornet
| 07. 20. 2016
In 2004 the editors of the journal Foreign Policy asked several prominent intellectuals to identify the world’s most dangerous idea. Surprisingly political scientist Francis Fukuyama’s choice was transhumanism. He described it as a movement “to liberate the human race from its biological constraints”. Its supporters, he said, want to “wrest their biological destiny from evolution's blind process of random variation and adaptation and move to the next stage as a species”.
Most people would ask, “Are you kidding?” In fact, the transhumanist projects which surface in the media do sound improbable, not to say loopy. Here are three which have been widely reported.
- Elon Musk, the American billionaire boss of Tesla and Space X, recently told a conference of programmers in San Francisco that humans need to augment their brain power with “neural lace”, a fine mesh integrated into the brain which would link the brain directly to the internet. If we fail to keep pace with artificial intelligence, we will become house pets for “ultra-intelligent AI”, he said. “I don’t love the idea of being a house cat,” he...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...